title: Nedocromil sodium: a review of clinical studies.
abstract: Nedocromil sodium is a new compound for the long-term treatment of bronchial asthma. Its effect has been studied in prevention of bronchospasm induced by a variety of stimuli showing a broader spectrum of activity than SCG. Its clinical efficacy has been demonstrated in a number of trials involving patients regardless of asthma type.
authors.affiliation: Medical Department, Fisons Farmaceutici S.p.A., Rome, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Ruggieri
authors.forename: F
authors.initials: F
authors.lastname: Patalano
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D001249:Asthma / Q000175:diagnosis / Q000188:drug therapy*; D001985:Bronchial Provocation Tests; D002986:Clinical Trials as Topic; D006801:Humans; D017835:Nedocromil; D015363:Quinolones / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D015363:Quinolones; D017835:Nedocromil